Company intelligence / Profile preview

International Institutional

Miami, Florida, United States

Ownership: Private
Development stage: Other

Overview

International Institutional Review Board (IIRB) was an independent central institutional review board that provided ethical review services for human subject research. The company specialized in the review of clinical trial protocols and informed consent forms to ensure the protection of the rights and welfare of research participants. IIRB served pharmaceutical, biotech, and medical device companies, as well as contract research organizations (CROs) and academic institutions. In 2013, the company was acquired by Advarra (formerly Chesapeake IRB) to expand its reach in the clinical research oversight market.

Industry: Contract Research Organization

Beyond the preview

Go deeper on International Institutional.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Institutional.

Explore the full profile